Thomas Idorn is leading the medical & science kidney team and is involved in various strategic and cross-functional kidney activities. He has worked as a medical specialist focusing on cardio-renal clinical trials in the Novo Nordisk headquarter in Copenhagen, Denmark since 2016. Among others he has been heavily involved in the LEADER, FLOW and REMODEL trials and is an internal member of the FLOW steering committee..